Skip to main content

Table 1 Clinicopathological variables of BC patients

From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysis

Characteristic Status Number of patients
Stage I 8 (16%)
II 15 (30%)
III 12 (24%)
IV 9 (18%)
Unknown 6 (12%)
Age  < 45 20 (40%)
 > 45 24 (48%)
Unknown 6 (12%)
Lymph node metastasis Yes 17 (34%)
No 26 (52%)
Unknown 7 (14%)
Tumor size (TS)  < 2 cm 15 (30%)
5 > TS > 2 5 (10%)
 > 5 cm 29 (58%)
Unknown 1 (2%)
Menopausal status Yes 12 (24%)
No 15 (30%)
Unknown 23 (46%)
ER receptor Positive 14 (28%)
Negative 13 (26%)
Unknown 23 (46%)
PR receptor Positive 19 (38%)
Negative 21 (42%)
Unknown 10 (20%)
HER2/neu receptor Positive 12 (24%)
Negative 21 (42%)
Unknown 17 (34%)